JBC Ideal method for primary cell transfection

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M405482200 on October 27, 2004

J. Biol. Chem., Vol. 280, Issue 2, 1272-1283, January 14, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/2/1272    most recent
M405482200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Louis, K.
Right arrow Articles by Mari, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Louis, K.
Right arrow Articles by Mari, B.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Tumor Cell-mediated Induction of the Stromal Factor Stromelysin-3 Requires Heterotypic Cell Contact-dependent Activation of Specific Protein Kinase C Isoforms*

Krystel Louis{ddagger}§, Nathalie Guérineau¶, Olivia Fromigué{ddagger}||, Virginie Defamie{ddagger}, Alejandra Collazos¶, Patrick Anglard**, Margaret A. Shipp{ddagger}{ddagger}, Patrick Auberger{ddagger}, Dominique Joubert¶, and Bernard Mari{ddagger}§§

From the {ddagger}INSERM U526, IFR50, Faculté de Médecine Pasteur, 06107 Nice, France, the INSERM U469, CCIPE, 34094 Montpellier, France, the **INSERM U575, Université Louis Pasteur, 67084 Strasbourg, France, and the {ddagger}{ddagger}Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115

Stromelysin-3 (ST3, MMP-11) has been shown to be strongly overexpressed in stromal fibroblasts of most invasive human carcinomas. However, the molecular mechanisms leading to ST3 expression in nonmalignant fibroblasts remain unknown. The aim of the present study was to analyze the signaling pathways activated in normal pulmonary fibroblasts after their interaction with non-small cell lung cancer (NSCLC) cells and leading to ST3 expression. The use of selective signaling pathway inhibitors showed that conventional and novel protein kinase Cs (PKC) were required for ST3 induction, whereas Src kinases exerted a negative control. We observed by both conventional and real time confocal microscopy that green fluorescent protein-tagged PKC{alpha} and PKC{epsilon}, but not PKC{delta}, transfected in fibroblasts, accumulate selectively at the cell-cell contacts between fibroblasts and tumor cells. In agreement, RNAi-mediated depletion of PKC{alpha} and PKC{epsilon}, but not PKC{delta} significantly decreased co-culture-dependent ST3 production. Finally, a tetracycline-inducible expression model allowed us to confirm the central role of these PKC isoforms and the negative regulatory function of c-Src in the control of ST3 expression. Altogether, our data emphasize signaling changes occurring in the tumor microenvironment that may define new stromal targets for therapeutic intervention.


Received for publication, May 17, 2004 , and in revised form, September 27, 2004.

* This work was supported in part by INSERM, University of Nice-Sophia Antipolis, the Fondation de France, and the Association pour la Recherche Contre le Cancer Contract 3355. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Supported by a fellowship from the Ligue Nationale contre Le Cancer.

|| Supported by a fellowship from the Fondation de France. Present address: INSERM U606, Hôpital Lariboisière, rue Ambroise Paré, 75475 Paris, France.

§§ To whom correspondence should be addressed: INSERM U526, Faculté deMédecine Pasteur, 06107 Nice, France. Tel.: 33-493-377-017; Fax: 33-493-817-852; E-mail: bernard.mari{at}unice.fr.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
B. A. Teicher
Protein kinase C as a therapeutic target.
Clin. Cancer Res., September 15, 2006; 12(18): 5336 - 5345.
[Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
A. Collazos, B. Diouf, N. C. Guerineau, C. Quittau-Prevostel, M. Peter, F. Coudane, F. Hollande, and D. Joubert
A Spatiotemporally Coordinated Cascade of Protein Kinase C Activation Controls Isoform-Selective Translocation.
Mol. Cell. Biol., March 1, 2006; 26(6): 2247 - 2261.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.